Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Azithromycin promotes proliferation, and inhibits inflammation in nasal epithelial cells in primary ciliary dyskinesia

Z. Varenyiova, LS. Rojas-Hernandez, J. Spano, V. Capek, Y. Rosenberg-Hasson, T. Holmes, C. Milla

. 2023 ; 13 (1) : 14453. [pub] 20230902

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Primary ciliary dyskinesia (PCD) is a genetic disorder associated with recurrent and chronic respiratory infections due to functional defects of motile cilia. In this study, we aimed to elucidate inflammatory and proliferative responses in PCD respiratory epithelium and evaluate the effect of Azithromycin (AZT) on these responses. Airway basal cells (BCs) were isolated from nasal samples of Wild-type (WT) epitope of healthy donors and PCD donors with bi-allelic mutations in DNAH5, DNAH11 and CCDC39. Cells were expanded in vitro and stimulated with either Lipopolysaccharide (LPS) or vehicle control. Post stimulation, cells were treated with either Azithromycin (AZT) or vehicle control. Cell proliferation was imaged in real-time. Separately, BCs from the same donors were expanded and grown at an air-liquid interface (ALI) to generate a multi-ciliated epithelium (MCE). Once fully mature, cells were stimulated with LPS, AZT, LPS + AZT or vehicle control. Inflammatory profiling was performed on collected media by cytokine Luminex assay. At baseline, there was a significantly higher mean production of pro-inflammatory cytokines by CCDC39 BCs and MCEs when compared to WT, DNAH11 and DNAH5 cells. AZT inhibited production of cytokines induced by LPS in PCD cells. Differences in cell proliferation were noted in PCD and this was also corrected with AZT treatment.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016294
003      
CZ-PrNML
005      
20231026110042.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-023-41577-5 $2 doi
035    __
$a (PubMed)37660113
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Varenyiova, Zofia $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. z.varenyiova@gmail.com
245    10
$a Azithromycin promotes proliferation, and inhibits inflammation in nasal epithelial cells in primary ciliary dyskinesia / $c Z. Varenyiova, LS. Rojas-Hernandez, J. Spano, V. Capek, Y. Rosenberg-Hasson, T. Holmes, C. Milla
520    9_
$a Primary ciliary dyskinesia (PCD) is a genetic disorder associated with recurrent and chronic respiratory infections due to functional defects of motile cilia. In this study, we aimed to elucidate inflammatory and proliferative responses in PCD respiratory epithelium and evaluate the effect of Azithromycin (AZT) on these responses. Airway basal cells (BCs) were isolated from nasal samples of Wild-type (WT) epitope of healthy donors and PCD donors with bi-allelic mutations in DNAH5, DNAH11 and CCDC39. Cells were expanded in vitro and stimulated with either Lipopolysaccharide (LPS) or vehicle control. Post stimulation, cells were treated with either Azithromycin (AZT) or vehicle control. Cell proliferation was imaged in real-time. Separately, BCs from the same donors were expanded and grown at an air-liquid interface (ALI) to generate a multi-ciliated epithelium (MCE). Once fully mature, cells were stimulated with LPS, AZT, LPS + AZT or vehicle control. Inflammatory profiling was performed on collected media by cytokine Luminex assay. At baseline, there was a significantly higher mean production of pro-inflammatory cytokines by CCDC39 BCs and MCEs when compared to WT, DNAH11 and DNAH5 cells. AZT inhibited production of cytokines induced by LPS in PCD cells. Differences in cell proliferation were noted in PCD and this was also corrected with AZT treatment.
650    _2
$a lidé $7 D006801
650    12
$a azithromycin $x farmakologie $7 D017963
650    _2
$a lipopolysacharidy $x toxicita $7 D008070
650    _2
$a epitelové buňky $7 D004847
650    _2
$a zánět $x farmakoterapie $7 D007249
650    _2
$a proliferace buněk $7 D049109
650    _2
$a cytokiny $7 D016207
650    12
$a poruchy ciliární motility $7 D002925
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rojas-Hernandez, Laura S $u Center for Excellence in Pulmonary Biology, Stanford University, Palo Alto, CA, USA
700    1_
$a Spano, Jacquelyn $u Center for Excellence in Pulmonary Biology, Stanford University, Palo Alto, CA, USA
700    1_
$a Capek, Vaclav $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Rosenberg-Hasson, Yael $u Human Immune Monitoring Center, Stanford University, Stanford, CA, USA
700    1_
$a Holmes, Tyson $u Human Immune Monitoring Center, Stanford University, Stanford, CA, USA
700    1_
$a Milla, Carlos $u Center for Excellence in Pulmonary Biology, Stanford University, Palo Alto, CA, USA
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 14453
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37660113 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110037 $b ABA008
999    __
$a ok $b bmc $g 2000047 $s 1202656
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 1 $d 14453 $e 20230902 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20231013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...